Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT for Cognitive Function in T1D
NCT06496412Recruiting
- Sponsor
- The Second Xiangya Hospital
- Start
- Apr 2024
- Primary completion
- Dec 2026
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Randomised, triple-blind trial in type 1 diabetes mellitus (T1D) comparing Fecal Microbiota Transplantation with Placebo (2 arms). Primary endpoints: Average change in Z-scores for memory and executive domain-related assessments at 24 weeks, Auditory Verbal Learning Test at 24 weeks and 9 more. Started Apr 2024; status: recruiting.
02
Drugs
allogeneic fecal microbiota
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT06496412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06496412.